18-45916110-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_020964.3(EPG5):c.3481C>T(p.Arg1161*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020964.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPG5 | NM_020964.3 | c.3481C>T | p.Arg1161* | stop_gained | 19/44 | ENST00000282041.11 | NP_066015.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPG5 | ENST00000282041.11 | c.3481C>T | p.Arg1161* | stop_gained | 19/44 | 1 | NM_020964.3 | ENSP00000282041.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249504Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135356
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727216
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Vici syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Jan 17, 2019 | This variant is interpreted as a Pathogenic for Vici syndrome, autosomal recessive. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PVS1 => Predicted nullvariant in a gene where LOF is a known mechanism of disease. PM3 => For recessive disorders, detected in trans with a pathogenic variant (PMID:26917586). - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change creates a premature translational stop signal (p.Arg1161*) in the EPG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EPG5 are known to be pathogenic (PMID: 23222957, 23674064). This variant is present in population databases (rs587776940, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Vici syndrome (PMID: 23222957). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 39982). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2013 | - - |
EPG5-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 02, 2024 | The EPG5 c.3481C>T variant is predicted to result in premature protein termination (p.Arg1161*). This variant has been reported in the apparently homozygous state in one individual with Vici syndrome (Table 1, Cullup T et al. 2012. PubMed ID: 23222957; Table 1, Byrne S et al. 2016. PubMed ID: 26917586). This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in EPG5 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at